Armistice Capital
22
52M
22
1
20
- Areas of investment
Summary
Besides, a startup needs to be aged 11-15 years to get the investment from the fund. Among the most popular fund investment industries, there are Medical, Manufacturing. Among the most popular portfolio startups of the fund, we may highlight Addex Therapeutics, Medigus.
The overall number of key employees were 1.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the Armistice Capital, startups are often financed by Varuma AG, Sofinnova Partners, SR One. The meaningful sponsors for the fund in investment in the same round are Senvest Capital, Sabby Management, OrbiMed. In the next rounds fund is usually obtained by Hercules Bioventure Partners, Michael J. Fox Foundation.
Deals in the range of 5 - 10 millions dollars are the general things for fund. The fund is constantly included in less than 2 deals per year. The higher amount of exits for fund were in 2018. The high activity for fund was in 2013.
Investments analytics
Analytics
- Total investments
- 22
- Lead investments
- 1
- Exits
- 20
- Investments by industry
- Biotechnology (19)
- Health Care (13)
- Pharmaceutical (11)
- Medical (7)
- Biopharma (6) Show 10 more
- Investments by region
-
- United States (16)
- United Kingdom (1)
- Belgium (1)
- France (2)
- Israel (1) Show 1 more
- Peak activity year
- 2024
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 14
- Avg. valuation at time of investment
- 5M
- Group Appearance index
- 0.77
- Avg. company exit year
- 3
- Avg. multiplicator
- 0.14
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.